Esperion Therapeutics Inc...

NASDAQ: ESPR · Real-Time Price · USD
0.78
-0.11 (-12.63%)
At close: May 09, 2025, 3:43 PM
-12.63%
Bid 0.74
Market Cap 154.95M
Revenue (ttm) 332.31M
Net Income (ttm) -51.74M
EPS (ttm) -0.28
PE Ratio (ttm) -2.79
Forward PE -4.14
Analyst Buy
Ask 0.83
Volume 10,760,451
Avg. Volume (20D) 4,566,593
Open 0.91
Previous Close 0.89
Day's Range 0.73 - 0.93
52-Week Range 0.73 - 3.94
Beta 0.74

About ESPR

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ESPR
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ESPR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Esperion Therapeutics has released their quartely earnings on May 6, 2025:
  • Revenue of $65M exceeds estimates by $10.8M, with -52.81% YoY decline.
  • EPS of -0.21 misses estimates by -0.06, with -161.76% YoY decline.
  • 2 months ago
    +12.03%
    Esperion Therapeutics shares are trading higher af... Unlock content with Pro Subscription
    4 months ago
    +5.58%
    Esperion Therapeutics shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and announced a price target of $8.